Oligonucleotide

Dalton invests big in oligos

Dalton invests big in oligos

By Gregory Roumeliotis

Contract manufacturer Dalton has announced the completion of its
oligonucleotide (oligos) manufacturing facility, in a $500,000
(€400,000) investment drive to dominate pilot and large-scale DNA
and RNA oligo synthesis.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers